• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[冠心病患者组织型纤溶酶原激活剂及其快速抑制剂的昼夜变化研究]

[A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease].

作者信息

Chen Z Y

机构信息

Diagnostic Department, Qingdao Medical College.

出版信息

Zhonghua Xin Xue Guan Bing Za Zhi. 1993 Jun;21(3):163-4, 188.

PMID:8243232
Abstract

In our study, we measured resting tissue-type plasminogen activator(t-PA) activity and resting plasminogen activator inhibitor-1 (PAI-1) activity in 15 healthy men and in 20 patients (male) with coronary heart disease in the morning and evening. Resting t-PA activity was lower (P < 0.05) in controls and was significantly lower (P < 0.001) in patients in the morning compared with that in the evening. In contrast, PAI-1 activity was significantly higher (P < 0.001) in controls and was also significantly higher (P < 0.001) in patients in the morning compared with that in the evening. t-PA activity in patients compared with that in controls was significantly lower (P < 0.05) in the morning and the evening; PAI-1 activity in patients compared with that in controls was significantly higher (P < 0.001) in the morning and the evening. However, t-PA activity was significantly lower (P < 0.05) and PAI-1 activity was significantly higher (P < 0.05) in patients with myocardial infarction compared with anginal patients in the morning. Applying this clinical phenomenon that myocardial infarction and angina have often occurred in the morning, the relationship between time of onset of myocardial infarction and circadian variation of t-PA and PAI-1 was discussed.

摘要

在我们的研究中,我们于早晨和晚上测量了15名健康男性以及20名男性冠心病患者的静息组织型纤溶酶原激活物(t-PA)活性和静息纤溶酶原激活物抑制剂-1(PAI-1)活性。与晚上相比,早晨时对照组的静息t-PA活性较低(P<0.05),而患者的静息t-PA活性显著更低(P<0.001)。相反,早晨时对照组的PAI-1活性显著更高(P<0.001),患者的PAI-1活性与晚上相比也显著更高(P<0.001)。早晨和晚上时,患者的t-PA活性与对照组相比均显著更低(P<0.05);早晨和晚上时,患者的PAI-1活性与对照组相比均显著更高(P<0.001)。然而,早晨时,与心绞痛患者相比,心肌梗死患者的t-PA活性显著更低(P<0.05),PAI-1活性显著更高(P<0.05)。鉴于心肌梗死和心绞痛常发生在早晨这一临床现象,我们探讨了心肌梗死发病时间与t-PA和PAI-1昼夜变化之间的关系。

相似文献

1
[A study on the circadian variation of tissue-type plasminogen activator and its rapid inhibitor in patients with coronary heart disease].[冠心病患者组织型纤溶酶原激活剂及其快速抑制剂的昼夜变化研究]
Zhonghua Xin Xue Guan Bing Za Zhi. 1993 Jun;21(3):163-4, 188.
2
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.不稳定型冠状动脉疾病和急性心肌梗死患者血浆中纤溶酶原激活物抑制剂和组织纤溶酶原激活物水平的昼夜波动。
Thromb Haemost. 1988 Dec 22;60(3):372-6.
3
[Problems in measuring parameters of the fibrinolytic system: circadian rhythm of tissue-type plasminogen activator and plasminogen activator inhibitor].[纤维蛋白溶解系统参数测量中的问题:组织型纤溶酶原激活物和纤溶酶原激活物抑制剂的昼夜节律]
Klin Wochenschr. 1988;66 Suppl 12:62-7.
4
Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1).组织型纤溶酶原激活物及其快速抑制剂(PAI-1)的昼夜变化。
Circulation. 1989 Jan;79(1):101-6. doi: 10.1161/01.cir.79.1.101.
5
Evaluation of tissue plasminogen activator and plasminogen activator inhibitor-I levels in acute myocardial infarction.急性心肌梗死中组织型纤溶酶原激活剂和纤溶酶原激活物抑制剂 -I 水平的评估。
J Cardiol. 1996 Apr;27(4):171-8.
6
Effect of isotretinoin on endogenous tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor 1 (PAI-1) in humans.异维A酸对人体内源性组织型纤溶酶原激活物(t-PA)和纤溶酶原激活物抑制剂1(PAI-1)的影响。
Thromb Haemost. 1993 Dec 20;70(6):1005-8.
7
Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.冠心病患者与非冠心病患者抑郁情绪与纤溶酶原激活物抑制剂、组织纤溶酶原激活物及纤维蛋白原水平的关系。
Am J Cardiol. 2006 May 1;97(9):1287-91. doi: 10.1016/j.amjcard.2005.11.062. Epub 2006 Mar 20.
8
Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.酒精性肝硬化中的高纤溶状态:1型纤溶酶原激活物抑制物相对缺乏
Thromb Res. 2008;121(5):675-80. doi: 10.1016/j.thromres.2007.07.008. Epub 2007 Sep 17.
9
Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.不稳定型心绞痛患者的透壁纤维蛋白溶解活性
Coron Artery Dis. 1996 Jan;7(1):45-9.
10
[Levels of tissue-type plasminogen activator (T-PA), its inhibitor (PAI-1) and fibrinogen in the blood of patients with type 1 and 2 diabetes mellitus].[1型和2型糖尿病患者血液中组织型纤溶酶原激活物(T-PA)、其抑制剂(PAI-1)和纤维蛋白原的水平]
Cas Lek Cesk. 1996 Mar 20;135(6):174-7.